Sleep medication helped cannabis users sleep during early withdrawal but did not significantly boost quit rates
In a 12-week trial of 127 adults seeking cannabis cessation, zolpidem prevented early withdrawal sleep disturbance but did not significantly increase abstinence rates (27% vs 15% on placebo), with high dropout in both groups.
Quick Facts
What This Study Found
Placebo participants but not zolpidem-XR participants showed significant sleep disturbance during week 1 of cannabis cessation. Abstinence rates were numerically higher with zolpidem-XR (27% vs 15%) but not statistically significant. Sleep disturbance emerged in the medication group after treatment stopped. Treatment retention was poor (about 50% dropout in both groups).
Key Numbers
127 participants; 27% abstinent on zolpidem-XR vs 15% on placebo (not significant); ~50% dropout in both groups; sleep disturbance prevented during medication but emerged after stopping; objective polysomnography used
How They Did This
Twelve-week randomized, double-blind, placebo-controlled trial of 127 adults with cannabis use disorder. All received computerized behavioral therapy and abstinence-based contingency management. Zolpidem-XR or placebo was provided during treatment. In-home ambulatory polysomnography measured sleep objectively.
Why This Research Matters
Sleep disturbance is one of the most common reasons people relapse when trying to quit cannabis. This trial provides important evidence that pharmacological sleep support can help during early withdrawal.
The Bigger Picture
The rebound sleep disturbance after stopping zolpidem suggests that simply delaying withdrawal symptoms is insufficient. Longer or different approaches to managing cannabis withdrawal sleep problems may be needed.
What This Study Doesn't Tell Us
Not powered to detect significant differences in abstinence; high dropout rate reduces interpretability; medication adherence was challenging; sleep medication stopped at end of treatment causing rebound; unclear optimal treatment duration
Questions This Raises
- ?Would a longer course of sleep medication improve cannabis cessation?
- ?Would non-pharmacological sleep interventions (CBT-I) provide more durable benefits?
- ?Is sleep disturbance a mediator or just a correlate of cannabis relapse?
Trust & Context
- Key Stat:
- 27% vs 15% abstinence (not significant); 50% dropout
- Evidence Grade:
- Well-designed RCT with objective sleep measurement, but underpowered for the primary outcome and hampered by high attrition.
- Study Age:
- 2024 study
- Original Title:
- Randomized controlled trial of zolpidem as a pharmacotherapy for cannabis use disorder.
- Published In:
- Journal of substance use and addiction treatment, 156, 209180 (2024)
- Authors:
- Lee, Dustin C(7), Schlienz, Nicolas J(7), Herrmann, Evan S(10), Martin, Erin L, Leoutsakos, Jeannie, Budney, Alan J, Smith, Michael T, Tompkins, D Andrew, Hampson, Aidan J, Vandrey, Ryan
- Database ID:
- RTHC-05462
Evidence Hierarchy
Frequently Asked Questions
Did sleep medication help people quit cannabis?
It helped with sleep but not significantly with quitting. Zolpidem-XR prevented the sleep problems that typically occur in the first week of cannabis cessation, and numerically more participants quit (27% vs 15%), but the difference was not statistically significant.
What happened when the medication stopped?
Sleep disturbance that was prevented during medication treatment emerged after zolpidem-XR was discontinued, suggesting the medication delayed rather than resolved withdrawal-related sleep problems. About half of participants in both groups dropped out before completing the trial.
Read More on RethinkTHC
- 30-days-without-weed
- 420-sober-survival-guide
- 6-months-sober-weed-what-to-expect
- 90-days-no-weed
- CBT-cannabis-recovery
- benefits-of-quitting-weed
- boredom-after-quitting-weed
- boredom-after-quitting-weed-nothing-fun
- cannabis-dependence-physical-psychological-addiction-science
- cannabis-perception-vs-evidence-gap
- cannabis-relapse-cycle-pattern
- cannabis-use-disorder-test
- cold-turkey-vs-taper-quit-weed
- creativity-without-weed-quitting-artist-musician
- cross-addiction-quit-weed-start-drinking
- dating-sober-after-quitting-weed
- exercise-quitting-weed-anxiety-brain
- grieving-quitting-weed-loss
- help-someone-quit-weed
- hobbies-after-quitting-weed
- how-to-quit-weed
- identity-after-quitting-weed
- is-weed-addictive
- is-weed-addictive-science
- journaling-weed-withdrawal
- leaving-stoner-culture-identity
- marijuana-anonymous-SMART-recovery-compare
- meditation-mindfulness-weed-withdrawal
- money-saved-quitting-weed-calculator
- one-year-sober-weed
- partner-still-smokes-weed
- partner-still-smokes-weed-quitting
- pink-cloud-sobriety-cannabis
- quit-weed-cold-turkey
- quit-weed-or-cut-back-which-is-better
- quit-weed-regret-went-back
- quitting-weed-20s
- quitting-weed-30s
- quitting-weed-after-years
- quitting-weed-and-alcohol
- quitting-weed-creativity
- quitting-weed-during-crisis-divorce-job-loss
- quitting-weed-exercise
- quitting-weed-face-changes-skin
- quitting-weed-grief-loss-coping
- quitting-weed-legal-state
- quitting-weed-success-stories
- quitting-weed-triggers-environment
- quitting-weed-weight-loss-gain
- rehab-for-weed-addiction-necessary
- relapsed-smoking-weed-what-to-do
- relapsed-weed
- should-i-quit-weed
- signs-of-cannabis-use-disorder
- sober-music-festival-concert-without-weed
- supplements-weed-withdrawal
- telling-friends-quitting-weed
- weed-relapse-prevention-plan
- weed-relapse-why-it-happens
- weed-ritual-replacement
- weed-ruined-relationships
- weed-social-media-triggers-quit
- weed-vape-pen-addiction
Cite This Study
https://rethinkthc.com/research/RTHC-05462APA
Lee, Dustin C; Schlienz, Nicolas J; Herrmann, Evan S; Martin, Erin L; Leoutsakos, Jeannie; Budney, Alan J; Smith, Michael T; Tompkins, D Andrew; Hampson, Aidan J; Vandrey, Ryan. (2024). Randomized controlled trial of zolpidem as a pharmacotherapy for cannabis use disorder.. Journal of substance use and addiction treatment, 156, 209180. https://doi.org/10.1016/j.josat.2023.209180
MLA
Lee, Dustin C, et al. "Randomized controlled trial of zolpidem as a pharmacotherapy for cannabis use disorder.." Journal of substance use and addiction treatment, 2024. https://doi.org/10.1016/j.josat.2023.209180
RethinkTHC
RethinkTHC Research Database. "Randomized controlled trial of zolpidem as a pharmacotherapy..." RTHC-05462. Retrieved from https://rethinkthc.com/research/lee-2024-randomized-controlled-trial-of
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.